quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:00:00·542d
PRRelease
Ambrx Biopharma Inc. logo
Kura Oncology Inc. logo
Atrium Therapeutics Inc. logo

Cartography Announces Appointment of Troy Wilson, Ph.D., J.D., to its Board of Directors

AMAM· Ambrx Biopharma Inc.KURA· Kura Oncology Inc.RNA· Atrium Therapeutics Inc.
Health Care
Original source

Companies

  • AMAM
    Ambrx Biopharma Inc.
    Health Care
  • KURA
    Kura Oncology Inc.
    Health Care
  • RNA
    Atrium Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 14KURAUpdateLake Street$23.00
  • Mar 11RNAUpdateWells Fargo$25.00
  • Sep 17RNAUpdateRoth Capital$62.00
  • Sep 4KURAUpdateGuggenheim-
  • Jul 10RNAUpdateGoldman$55.00
  • Jun 24RNAUpdateBernstein$50.00

Related

  • PR3h
    Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML
  • PR1d
    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
  • INSIDER1d
    SEC Form 4 filed by Kenney Stephanie
  • INSIDER1d
    SEC Form 4 filed by Hughes Steven George
  • INSIDER1d
    SEC Form 4 filed by Winslow Brendan R.
  • INSIDER1d
    SEC Form 4 filed by Gallagher Kathleen P.
  • INSIDER1d
    SEC Form 4 filed by Hoyos Rocio Martin
  • INSIDER1d
    SEC Form 4 filed by Younis Husam
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022